Stamoulis Christiana
- SEC CIK
- 0001502917
In the past year, 1 open-market sale filing worth $540.9K and no purchases.
Current role at each company
- HOLX Hologic IncDirectoras of Apr 9, 2026
- MNKTQ Keenova Therapeutics plcPresident and CFOas of Feb 26, 2026
- INCY Incyte CorpEVP & Chief Financial Officeras of Jul 16, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $540.9K
- 1 filing
- Net
- −$540.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Stamoulis Christiana as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HOLX Hologic Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 (view filing) | Oct 20 | 2 days | Stamoulis ChristianaDirector | SSale | −7.40K | $73.07 | −$540.9K | −13.5%47.3K after | 10b5-1 |
| Jul 19, 2024 (view filing) | Jul 17 | 2 days | Stamoulis ChristianaDirector | SSale | −9.04K | $79.50 | −$718.6K | −16.6%45.5K after | 10b5-1 |